Martin H. Voss

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• From diversity to function: microbiome precision in RCC

  Nature Reviews Urology · 2026-04-08

• Abstract 2862: Dietary animal protein intake and progression-free survival (PFS) of patients (pts) with advanced urothelial cancer (UC) and renal cell carcinoma (RCC) on immune checkpoint blockade (ICB)

  Cancer Research · 2026-04-03

• "Selbstreferenzielle Multiskalenmodellierung und -simulation der Ausbreitung schwerer Infektionskrankheiten (SEMSAI)"; Teilprojekt "Bevölkerungsverhalten und Feedback-Effekte"

  TIB Repositorium · 2026-03-31

• Associations between psychological dispositions, pandemic-related variables and protection motivation theory determinants: a cross-sectional studyPreprint

  Research Square · 2026-03-11

• Clinical outcomes and tolerability of ipilimumab/nivolumab in older (≥70 years) versus younger patients with metastatic clear cell RCC: A multi-institutional analysis of 514 patients.

  Journal of Clinical Oncology · 2026-03-01

• A multi-institution analysis of outcomes with first-line ipilimumab and nivolumab for 514 patients with metastatic clear cell renal cell carcinoma by number of doses.

  Journal of Clinical Oncology · 2026-03-01

• Sarcomatoid versus rhabdoid dedifferentiation and histologic grade-specific outcomes in metastatic clear cell renal cell carcinoma (mccRCC): A multi-institutional analysis of 514 patients.

  Journal of Clinical Oncology · 2026-03-01

• Cannabis Use During Immune Checkpoint Inhibitor Therapy Among Patients with Kidney Cancer and Melanoma

  Integrative Medicine Reports · 2026-01-01

• Mechanistic insights make cancer cachexia a targetable syndrome

  Nature Medicine · 2026-01-01

• Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

  UNC Libraries · 2025-12-19

• Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

  CA A Cancer Journal for Clinicians · 2025-12-13

• Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma

  European Urology Oncology · 2025-11-26 · 1 citations

• Supplementary Tables S1-S5 from Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade

  2025-11-25

• Supplementary Tables S6-S8 from Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade

  2025-11-25

• MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell Carcinoma

  European Urology · 2025-11-01

• Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling

  Cell Reports Medicine · 2025-10-30 · 3 citations

• 26Subgroup analysis of the efficacy and safety of cabozantinib ± atezolizumab in patients from CONTACT-03 who received first-line treatment with immuno-oncology–based combinations

  The Oncologist · 2025-10-01

• 1Pembrolizumab plus lenvatinib for previously untreated advanced non–clear cell renal cell carcinoma: 3-year follow-up of the phase 2 KEYNOTE-B61 study

  The Oncologist · 2025-10-01 · 1 citations

• Cannabis use among patients receiving immune checkpoint inhibitors.

  JCO Oncology Practice · 2025-10-01

• Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy alone

  Urologic Oncology Seminars and Original Investigations · 2025-09-11